GlassScriptPhysician profile
Jessica E Fu
NPI 1710185111
$1,979.63
in general payments reported to CMS, 2019-2025
31 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.32 · 2020: $78.10 · 2021: $340 · 2022: $595 · 2023: $441 · 2024: $206 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $936.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $936.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $419.28 | 2020-2025 | |
| Medtronic, INC. | $253.88 | 2023-2024 | Sonicision, V-Loc 180, Signia |
| Organon LLC | $153.97 | 2021-2024 | |
| Exeltis, USA INC. | $92.89 | 2022-2025 | Slynd |
| Therapeuticsmd, INC. | $91.56 | 2019-2022 | |
| Coopersurgical, INC. | $87.55 | 2020-2023 | Paragard T 380a |
| Myovant Sciences INC. | $79.41 | 2021-2022 | |
| Pfizer INC. | $79.22 | 2023-2024 | |
| Applied Medical Resources Corporation | $60.53 | 2025 | Gelpoint V-Path |
| Exact Sciences Corporation | $57.09 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $48.84 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $48.75 | 2023 | |
| Astellas Pharma US INC | $48.43 | 2025 | Veozah |
| Shield Therapeutics INC | $47.56 | 2023 | Accrufer |
| Merck Sharp & Dohme LLC | $44.42 | 2020-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $42.85 | 2023 | Quviviq |
| Ethicon US, LLC | $34.01 | 2022-2023 | Ethicon |
| Roche Diagnostics Corporation | $31.18 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $27.40 | 2021 | |
| Hologic Sales and Service, LLC | $27.05 | 2021 | |
| Teleflex LLC | $26.40 | 2025 | Quikclot |
| Sumitomo Pharma America, INC. | $24.92 | 2025 | Myfembree |
| Aspira Women'S Health INC | $24.64 | 2022 | |
| Novo Nordisk INC | $22.71 | 2021 | |
| Biogen, INC. | $19.21 | 2025 | Zurzuvae |
| Heron Therapeutics, INC. | $17.50 | 2023 | Zynrelef |
| Lucid Diagnostics INC. | $16.52 | 2022 | |
| Innovation Technologies INC | $14.02 | 2025 | Irrisept |
| Abbott Laboratories | $13.24 | 2024 | Proclaim |
| Pacira Pharmaceuticals Incorporated | $12.81 | 2023 | Exparel |
| Lupin INC. | $11.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Fu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.